- $38.63m
- $39.36m
- $0.12m
- 27
- 15
- 63
- 27
Annual balance sheet for Daxor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | N-CSR | N-CSR | N-CSR | N-CSR | N-CSR |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Total Receivables | 0.263 | 0.054 | 0.038 | 0.026 | 0.019 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 16.6 | 25 | 30.3 | 34.9 | 36.6 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.878 | 3.83 | 1.29 | 0.859 | 0.84 |
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 15.7 | 21.2 | 29 | 34 | 35.8 |
| Total Liabilities & Shareholders' Equity | 16.6 | 25 | 30.3 | 34.9 | 36.6 |
| Total Common Shares Outstanding |